Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 2NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Ovarian Neoplasms 2Neuroblastoma 2Lymphoma, Non-Hodgkin 2Lymphoma 2Leukemia, Myeloid, Acute 2Leukemia 2Waldenstrom Macroglobulinemia 1Unspecified Adult Solid Tumor, Protocol Specific 1Thrombocythemia, Essential 1Primary Myelofibrosis 1Polycythemia Vera 1Pdgfra-Associated Chronic Eosinophilic Leukemia 1Neoplasms, Plasma Cell 1Neoplasms 1Myeloproliferative Disorders 1Multiple Myeloma 1Mouth Neoplasms 1Melanoma 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Immunoblastic 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Leukemia, Neutrophilic, Chronic 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Head and Neck Neoplasms 1Congenital Abnormalities 1

Interventions

Immunoenzyme Techniques 3Docetaxel 3N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide 2Immunohistochemistry 2AEG 35156 2temsirolimus 1sabarubicin 1halofuginone 1Trabectedin 1SB939 compound 1Reverse Transcriptase Polymerase Chain Reaction 1N-(6-chlorophenoxyhexyl)-N''-cyano-N''-4-pyridylguanidine 1Mass Spectrometry 1Immunologic Techniques 1Flow Cytometry 1Fenretinide 1Chromatography, Liquid 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Unspecified Adult Solid Tumor, Protocol Specific × Fenretinide × Clear all
NCT00387504 2013-09-12

Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors

California Cancer Consortium

Phase 1 Completed
21 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

Data powered by HemOnc (CC BY 4.0) Colophon âš¡